comparemela.com

Latest Breaking News On - Diagnostics business - Page 1 : comparemela.com

Health Canada Approves Nexstim NBS 6 System for Treatment of MDD

06.05.2024 - Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ( Nexstim or Company ) has received approval from Health Canada for the marketing and commercial .

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024

Conference Call and Webcast at 8:30AM Eastern Time NEW YORK, May 2, 2024 /PRNewswire/ Lucid Diagnostics Inc.   a commercial-stage, cancer prevention medical diagnostics company and.

Nexstim Plc: Managers Transactions, Forss

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.